NORD Issues Statement on Confirmation of New FDA Commissioner, Dr. Scott Gottlieb

Written by Christina Jensen on May 10, 2017

Washington, D.C., May 10, 2017—The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare diseases, issued the following statement on the confirmation by the U.S. Senate of Scott Gottlieb, M.D., as Commissioner of the Food and Drug Administration (FDA):

“We at the National Organization for… Read More